As expected, based on the known roles of ApoE level and APOE genetic variation in lipid metabolism and AD, overrepresentation of gene sets, and general biological function analyses implicated lipid- and AD-associated pathways (Fig. S7, Table S5). The gene discussed is APOE; the disease is Alzheimer disease.